Skip to main content
. 2021 Apr 16;12:640297. doi: 10.3389/fphar.2021.640297

FIGURE 1.

FIGURE 1

AGNHW pre-treatment ameliorated neurological deficit and decreased infarct size in MCAO rat model (A) Illustration of experimental schedule. (B) The degree of neurological function was assessed by Zea long’s scoring on a five-point scale 24 h after reperfusion (n = 15) (C,D) Infarct size was measured by TTC staining 24 h after reperfusion (n = 5). Representative image (C) and statistical analysis of results of TTC staining (D). Data are means ± S.D. ## p < 0.01, compared with the sham group; *p < 0.05 and **p < 0.01, compared with the vehicle group.